Zhong Zhao

This inventor holds 11 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Genzyme Corporation, Laboratoires Serono S.a., Merck Serono S. a.. Active years: 2007-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhong Zhao. Retrieved from https://idiyas.com/inventor/zhong-zhao-c008q7wl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 8)

% Patents Active = 36.4

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 53(Granted Patents)

Company Filing History:

Laboratoires Serono S.a.

Applied Research Systems Ars Holding N.v.

patents

Years Active: 2007-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12060349 - Glucosylceramide synthase inhibitors (2024-08-13),

2. 11008316 - Glucosylceramide synthase inhibitors (2021-05-18),

3. 10017523 - NAMPT inhibitors and methods (2018-07-10),

4. 8288398 - Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones (2012-10-16),

5. 8058305 - Pyrrolidine derivatives as prostaglandin modulators (2011-11-15),

6. 7863312 - Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors (2011-01-04),

7. 7635713 - Pyrrolidine derivatives as prostaglandin modulators (2009-12-22),

8. 7419999 - Gamma lactams as prostaglandin agonists and use thereof (2008-09-02),

9. 7410991 - Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors (2008-08-12),

10. 7335680 - Pyrrolidine derivatives as prostaglandin modulators (2008-02-26),

11. 7276531 - G-lactam derivatives as prostaglandin agonists (2007-10-02),

Title: Zhong Zhao: A Trailblazer in Innovation and Technology

Introduction:

Zhong Zhao, a renowned inventor based in Wayland, MA, USA, is paving the way for the next generation of inventors and entrepreneurs with his passion for innovation and relentless pursuit of excellence. With a impressive portfolio of 10 patents and groundbreaking inventions in the field of technology, Zhong Zhao is a true visionary in the ever-evolving landscape of innovation.

Latest Patents:

Among his latest patents, Zhong Zhao has developed cutting-edge inventions such as Glucosylceramide synthase inhibitors, which are invaluable in the treatment of metabolic diseases and cancer. Additionally, his work on NAMPT inhibitors and methods showcases his commitment to advancing therapeutic solutions for a wide range of medical challenges.

Career Highlights:

Having worked with prestigious companies like Laboratoires Serono S.A. and Merck Serono S. A., Zhong Zhao has honed his skills and expertise in the field of biotechnology and pharmaceuticals. His contributions have not only revolutionized the way we approach healthcare but have also set new standards for innovation in the industry.

Collaborations:

Throughout his career, Zhong Zhao has collaborated with esteemed professionals such as Gian Luca Araldi and Yihua Liao. These collaborations have not only led to groundbreaking inventions but have also fostered a culture of creativity and collaboration in the workplace.

Conclusion:

In conclusion, Zhong Zhao's dedication to innovation and technology continues to inspire and shape the future of inventors and entrepreneurs worldwide. His relentless pursuit of excellence and groundbreaking inventions stand as a testament to his ingenuity and vision in the world of patents and innovation.

Profile summary based on public USPTO records.